In conclusion, detection of aCL IgA, aβ2GPI IgA, aAnxV IgG/M, and aPS/PT IgG/M as a biomarker provides additive value in APS diagnosis, especially aCL IgA and aAnxV IgG. This evidence concerns the gene CD79A and autoimmune polyendocrinopathy.